- Adaptive Biotechnologies’ T-Detect test, which assesses the body’s T cell immune response to COVID-19 to detect recent or prior infection.
- Cue Health’s molecular at-home test, which detects genetic material from the virus that causes COVID-19 present in the nostrils. It’s the first molecular test authorized for at-home use without a prescription.
- Quidel’s at-home antigen test, which is authorized for prescription use and doesn’t require test samples to be sent to a lab.
- Visby Medical’s rapid, single-use PCR test, which can be used in a wide range of facilities, including urgent care clinics, pharmacies and universities.
More articles on supply chain:
Medtronic hires Walmart exec to run its supply chain
Devicemaker pulls fever scanner off the market after FDA warning
Global syringe supply may not meet vaccine demand
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.